Zhang Y - Search Results

1

Efficacy and Safety of Xinyue Capsule for Coronary Artery Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Jiang Z, Qu H, Zhang Y, Zhang F, Xiao W, Shi D, Gao Z, Chen K. Jiang Z, et al. Among authors: zhang f, zhang y. Evid Based Complement Alternat Med. 2021 Apr 8;2021:6695868. doi: 10.1155/2021/6695868. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33897802 Free PMC article. Review.

2

Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.

Zhang Y, Ma XJ, Shi DZ. Zhang Y, et al. PLoS One. 2015 Sep 14;10(9):e0137775. doi: 10.1371/journal.pone.0137775. eCollection 2015. PLoS One. 2015. PMID: 26367001 Free PMC article. Review.

3

Obstructive sleep apnea increases the risk of cardiac events after percutaneous coronary intervention: a meta-analysis of prospective cohort studies.

Qu H, Guo M, Zhang Y, Shi DZ. Qu H, et al. Among authors: zhang y. Sleep Breath. 2018 Mar;22(1):33-40. doi: 10.1007/s11325-017-1503-8. Epub 2017 Apr 18. Sleep Breath. 2018. PMID: 28421375

4

Effects of microbiota-driven therapy on inflammatory responses in elderly individuals: A systematic review and meta-analysis.

Qu H, Zhang Y, Chai H, Gao ZY, Shi DZ. Qu H, et al. Among authors: zhang y. PLoS One. 2019 Feb 6;14(2):e0211233. doi: 10.1371/journal.pone.0211233. eCollection 2019. PLoS One. 2019. PMID: 30726266 Free PMC article.

5

The Prognostic Value of Reticulated Platelets in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Zhao Y, Lai R, Zhang Y, Shi D. Zhao Y, et al. Among authors: zhang y. Front Cardiovasc Med. 2020 Oct 23;7:578041. doi: 10.3389/fcvm.2020.578041. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33195464 Free PMC article.

6

Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial.

Ma XJ, Duan WH, Zhang Y, Gao J, Guan BY, Chen KJ, Shi DZ. Ma XJ, et al. Among authors: zhang y. Chin J Integr Med. 2021 Nov;27(11):803-810. doi: 10.1007/s11655-021-2878-8. Epub 2021 Sep 16. Chin J Integr Med. 2021. PMID: 34532749 Clinical Trial.

7

The Association Between Remnant Cholesterol and the Estimated 10-Year Risk of a First Hard Cardiovascular Event.

Yang Z, Yang K, Shi J, Yang Q, Zhang Y, Gao J, Shi D, Qu H. Yang Z, et al. Among authors: zhang y. Front Cardiovasc Med. 2022 Jun 17;9:913977. doi: 10.3389/fcvm.2022.913977. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35783820 Free PMC article.

8

Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolization.

Zhang Y, Ma XJ, Guo CY, Wang MM, Kou N, Qu H, Mao HM, Shi DZ. Zhang Y, et al. Acta Pharmacol Sin. 2016 Apr;37(4):463-72. doi: 10.1038/aps.2015.147. Epub 2016 Feb 29. Acta Pharmacol Sin. 2016. PMID: 26924290 Free PMC article.

9

The role of microRNAs in prethrombotic status associated with coronary artery disease.

Gao J, Ma X, Zhang Y, Guo M, Shi D. Gao J, et al. Among authors: zhang y. Thromb Haemost. 2017 Feb 28;117(3):429-436. doi: 10.1160/TH16-07-0503. Epub 2016 Dec 22. Thromb Haemost. 2017. PMID: 28004061 Review.

10

ANRIL and atherosclerosis.

Chen L, Qu H, Guo M, Zhang Y, Cui Y, Yang Q, Bai R, Shi D. Chen L, et al. Among authors: zhang y. J Clin Pharm Ther. 2020 Apr;45(2):240-248. doi: 10.1111/jcpt.13060. Epub 2019 Nov 8. J Clin Pharm Ther. 2020. PMID: 31703157 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239,111 results

Search Page